Literature DB >> 27054930

From Gestational Hypertension and Preeclampsia to Atypical Hemolytic Uremic Syndrome.

Han-Mou Tsai1, Elizabeth Kuo.   

Abstract

BACKGROUND: Preeclampsia is a leading cause of morbidity and mortality during pregnancy. The variability of clinical features suggests that preeclampsia is not a single disease. Atypical hemolytic uremic syndrome, resulting from defective regulation of the alternative complement pathway, is less well known and may be mistaken for preeclampsia. CASE: We describe a woman with atypical hemolytic uremic syndrome who was given the diagnosis of gestational hypertension during her first pregnancy and preeclampsia and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome followed by thrombotic thrombocytopenic purpura and hemolytic uremic syndrome during her second pregnancy, before the correct diagnosis of atypical hemolytic uremic syndrome was recognized in the postpartum period of her third pregnancy. The patient was treated with anticomplement therapy and had a rapid improvement.
CONCLUSION: This case illustrates the importance of distinguishing atypical hemolytic uremic syndrome from preeclampsia.

Entities:  

Mesh:

Year:  2016        PMID: 27054930     DOI: 10.1097/AOG.0000000000001340

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat.

Authors:  Jean F Regal; Megan E Strehlke; Jenna M Peterson; Cameron R Wing; Jordan E Parker; Noel Fernando Nieto; Lynne T Bemis; Jeffrey S Gilbert; Sherry D Fleming
Journal:  Mol Immunol       Date:  2016-08-30       Impact factor: 4.407

Review 2.  The Complement Alternative Pathway and Preeclampsia.

Authors:  Layan Alrahmani; Maria Alice V Willrich
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 3.  Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.

Authors:  Arif Asif; Ali Nayer; Christian S Haas
Journal:  J Nephrol       Date:  2016-11-15       Impact factor: 3.902

4.  Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis.

Authors:  Gérard Socié; Marie-Pierre Caby-Tosi; Jing L Marantz; Alexander Cole; Camille L Bedrosian; Christoph Gasteyger; Arshad Mujeebuddin; Peter Hillmen; Johan Vande Walle; Hermann Haller
Journal:  Br J Haematol       Date:  2019-02-15       Impact factor: 6.998

5.  Effect of Nanoherbal Andaliman (Zanthoxylum acanthopodium) and Extra Virgin Olive Oil Combination on Preeclamptic Rats Liver Histology.

Authors:  Putri Cahaya Situmorang; Syafruddin Ilyas; Salomo Hutahaean; Rosidah Rosidah
Journal:  Open Access Maced J Med Sci       Date:  2019-07-14

6.  Pregnancy-Associated Atypical Hemolytic Uremic Syndrome: A Systematic Review.

Authors:  Megha Gupta; Shravya Govindappagari; Richard M Burwick
Journal:  Obstet Gynecol       Date:  2020-01       Impact factor: 7.623

7.  Diagnostic dilemma in postpartum associated hemolytic uremic syndrome in a 38th week pregnant 31-year-old Congolese: a case report.

Authors:  Marc Tshilanda; Ulrick Sidney Kanmounye; Céline Tendobi; Freddy Mbuyi
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-27       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.